Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 15, 2009, Pages 2563-2568

  Coyne, Daniel W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Chronic kidney disease; Dialysis; Ferumoxytol; Iron deficiency

Indexed keywords

FERAHEME; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERUMOXYTOL; INJECTAFER; IRON; IRON DEXTRAN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANEMIA; ARTHRALGIA; BLEEDING; CELLULITIS; CHRONIC KIDNEY DISEASE; CONSTIPATION; DIARRHEA; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; DRUG STRUCTURE; EDEMA; ENDOCARDITIS; FERRITIN BLOOD LEVEL; GANGRENE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPOTENSION; IRON DEFICIENCY ANEMIA; IRON THERAPY; NAUSEA; OSTEOMYELITIS; PERITONEAL DIALYSIS; REVIEW; VOMITING;

ANEMIA, IRON-DEFICIENCY; ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; FERROSOFERRIC OXIDE; HUMANS; INJECTIONS, INTRAVENOUS; RENAL INSUFFICIENCY, CHRONIC;

EID: 70349392501     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903224998     Document Type: Review

References (14)

1. Cuervo LG, Mahomed K. Treatments for iron deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2001;(2):CD003094
2. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47(suppl 3):1-146
3. Coyne DW, Kapoian T, Suki W, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol 2007;18:975-984 (Pubitemid 46434515)
4. Coyne DW. A comprehensive vision for intravenous iron therapy. Am J Kidney Dis 2008;52:S14-20
5. Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 1999;33:464-470 (Pubitemid 29107023)
6. Rodgers GM, Auerbach M, Cella D, et al. High-molecular weight iron dextran: a wolf in sheep's clothing? J Am Soc Nephrol 2008;19:833-834
7. Coyne DW, Adkinson NF, Nissenson AR, et al. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int 2003;63:217-224
8. Aronoff GR, Bennett WM, Blumenthal S, et al. United States Iron Sucrose Clinical Trials, G. Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. Kidney Int 2004;66:1193-1198
9. Landry R, Jacobs PM, Davis R, et al. Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients. Am J Nephrol 2005;25:400-410 (Pubitemid 41160999)
10. Ferumoxytol (Feraheme) Injection. FDA Package Insert. AMAG Pharmaceuticals, Inc. June 2009
11. Spinowitz BS, Kausz AT, Baptista J, et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol 2008;19:1599-1605
12. Provenzano R, Schiller B, Rao M, et al. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. Clin J AmSoc Nephrol 2009;4:386-393
13. Singh A, Patel T, Hertel J, etal. Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis 2008;52:907-915
14. Balakrishnan VS, Rao M, Kausz AT, et al. Physicochemical properties of ferumoxytol, a new intravenous iron preparation. Eur J Clin Invest 2009;39:489-496